购物车
- 全部删除
- 您的购物车当前为空
ZL006 是一种 nNOS/PSD-95 相互作用抑制剂,能够抑制 NMDA 受体介导的 NO 合成。
为众多的药物研发团队赋能,
让新药发现更简单!
ZL006 是一种 nNOS/PSD-95 相互作用抑制剂,能够抑制 NMDA 受体介导的 NO 合成。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 147 | 现货 | |
5 mg | ¥ 337 | 现货 | |
10 mg | ¥ 488 | 现货 | |
25 mg | ¥ 990 | 现货 | |
50 mg | ¥ 1,590 | 现货 | |
100 mg | ¥ 2,790 | 现货 | |
200 mg | ¥ 3,890 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 383 | 现货 |
产品描述 | ZL006 is an effective inhibitor of nNOS/PSD-95 interaction. ZL006 also inhibits NMDA receptor-mediated NO synthesis. |
体外活性 | ZL006 growth inhibition of BCECs is not found at a low concentration of 0.001, 0.01, 0.1, 1, and 10 μg/mL. The cytotoxicity of T7-P-LPs/ZL006 is obviously enhanced at the concentration of 10 μg/mL. Cellular uptake of ZL006 loads P-LPs and T7-P-LPs after incubation for 0.5 h at the concentrations range from 100 μg/mL to 600 μg/mL in BCECs [1][2]. |
体内活性 | T7-P-LPs/ZL006 displays a significant enhance in drug accumulation in the brain tissue due to its better brain targeting delivery compared with P-LPs/ZL006 and free ZL006. P-LPs/ZL006 and T7-P-LPs/ZL006 show a significant decrease in drug accumulation in the liver and kidney compared with free ZL006 [1]. |
分子量 | 328.15 |
分子式 | C14H11Cl2NO4 |
CAS No. | 1181226-02-7 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 29 mg/mL (88.37 mM) | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.